Pfizer and BioNTech’s vaccine reaches the last stages of human trials : Pharma News – 30 July: Pfizer and BioNTech have been proactive in their search for a Covid-19 vaccine. The initial stages of the clinical trial of their lead Covid-19 vaccine have shown promising results. Following this, the companies have announced that the beginning […]
Brinton Pharma has received DCGI’s approval for marketing Faviton in India: Pharma News – 26 July: Favipiravir was approved by the DCGI[1] in June 2020 under the emergency use authorization. This medication was found to be effective in treating Covid-19 patients. Clinical evidence obtained from various parts of the globe has proved its efficacy in
AstraZeneca’s Covid-19 vaccine passes the initial human trials: Pharma News 23 July- British drug firm, AstraZeneca has been working in collaboration with Oxford University for producing a Covid-19 vaccine. This vaccine is called as AZD1222. AZD1222 is a chimpanzee adenovirus viral vector vaccine. The adenovirus of this vaccine has been genetically modified to code for
Table of Contents Glenmark Pharma has reduced the price of Fabiflu tablets by 27%: Pharma news 16 July 2020 Glenmark Pharmaceuticals had launched its antiviral drug, Favipiravir, in the Indian market in June 2020. Initially, the price per tablet of Fabiflu was set at Rs.103. This drug was approved for the treatment of mild to
Pfizer and BioNTech’s mRNA vaccine will most likely hit the markets by the end of 2020: Pfizer and BioNTech had collaborated to produce an experimental Covid-19 vaccine called BNT162b1. Preliminary human testing of this vaccine had shown promising results against the SARS-CoV-2[1]. The phase 1/2 trials of this vaccine were conducted to establish its safety.
Table of Contents Pharma news – 9 July 2020 Mylan gears up to sell its generic version of Remdesivir at 4,800 rupees in India: Cipla and Hetero labs began the sale of their generic version of Remdesivir in India in June 2020. Hetero priced its generic version, Covifor at 5,400 rupees. Cipla however claimed that
Indian Government is reviewing the use of Remdesivir for Covid-19 following reports of liver damage The Union Health Ministry of India is currently reviewing the use of Remdesivir in the country. Multiple reports of liver damage in the Covid-19 patients treated with this drug have instigated this action. The side-effects of Remdesivir was one of
Sun Pharma launches Ilumya in the Japanese market Sun Pharma had announced the launch of its psoriasis drug, Ilumya, in the Japanese market on 29 June 2020. Ilumya is an innovative product of Sun Pharma that is used for plaque psoriasis.The drug firm has stated that one of its wholly-owned subsidiaries in Japan had received
1. Hindustan Antibiotic’s moves to explore opportunities in line with self-reliant India Around 70% of the active pharmaceutical ingredients (API) needed for the production of important drugs in India are imported from China. However, the current volatility between the two countries has instilled fear and uncertainty in the minds of everyone. To reduce this dependency,
India plans to reduce the import of API and other raw materials from China The military face-off between India and China has put both the countries in a frenzy. To prevent things from escalating downhill, both countries have resorted to talking things out smoothly. But despite this, precautionary measures are being adopted from both sides
